US Patent 10226280 Recovery and processing of human embryos formed in vivo

Patent 10226280 was granted and assigned to Previvo Genetics, Inc. on March, 2019 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Previvo Genetics, Inc.

Current Assignee

Previvo Genetics, Inc.

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

10226280

Date of Patent

March 12, 2019

Patent Application Number

14814252

Date Filed

July 30, 2015

Patent Primary Examiner

‌

Carrie R Dorna

Patent abstract

A kit having instructions for use for performing uterine lavage in a female patient includes a uterine lavage catheter configured for insertion into a woman's uterus to remove viable blastocysts from the uterus, and one or more first containers having a sufficient dosage amount of a GnRH antagonist to cause desynchronization of the endometrium of the patient prior to, during and/or following recovery of viable blastocysts from the uterus.